Establishing and applicating new diagnostic technology for obstructive sleep apnea-hypopnea syndrome based on AI technology

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037194

Enrollment

Unknown

Registered

2020-08-27

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea-hypopnea sydrome

Interventions

Gold Standard:polysomnography

Index test:AHI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Snoring with or without holding breath during sleep.

Exclusion criteria

Exclusion criteria: 1. Serious organ diseases (such as heart, liver, kidney, lung dysfunction), central nervous system diseases and other sleep disorders; 2. There are infectious diseases (such as tuberculosis, hepatitis, HIV, etc.); 3. Drinking alcohol or drug addiction; or using psychotropic drugs, tranquilizers, narcotics, etc.; 4. Have received OSAHS treatment: such as CPAP, surgery, and oral appliances.

Design outcomes

Primary

Measure	Time frame
AHI;SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactJian Guan

Shanghai Sixth People's Hospital

guanjian0606@sina.com+86 18930172210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026